The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: GlaxoSmithKline Executives Share Awards Vest

Fri, 14th Feb 2014 17:51

LONDON (Alliance News) - GlaxoSmithKline PLC Friday announced that a group of executives, including Chief Executive Officer Andrew Witty, had received shares after share options they had been awarded had vested.

The following executives share options from the company's 2011 performance share plan awards vested as follows:

 

 

Awards which have vested

 

Awards which have lapsed

 

Ordinary Shares

ADS

Ordinary Shares

ADS

Sir Andrew Witty*

196,634

 

297,421

 

Mr S Dingemans*

90,845

 

137,408

 

Dr M Slaoui*

 

68,345

 

103,376

Mr S Bicknell

23,596

 

35,690

 

Ms D Connelly

 

28,553

 

43,188

Mr A Hussain

57,952

 

87,656

 

Mr W Louv

 

19,926

 

30,139

Mr D Redfern

33,034

 

49,966

 

Ms C Thomas

46,405

 

70,191

 

Mr D Troy

 

36,451

 

55,134

Mr P Vallance

66,855

 

101,123

 

* denotes an Executive Director

The following executives share options from the company's 2011 deferred annual bonus awards vested as follows:

 

 

Nil Cost Option over Ordinary Shares

 

Conditional Awards of ADSs/Co-Investment Shares (ADSs)

Vested

Vested/Released

Sir Andrew Witty*

37,182

 

Dr Moncef Slaoui*

 

21,848

Mr S Bicknell

7,912

 

Ms D Connelly

 

5,280

Mr W Louv

 

2,392

Mr D Redfern

8,837

 

Ms C Thomas

1,967

 

Mr D Troy

 

10,950

Mr P Vallance

17,569

 

* Denotes an Executive Director

The following executives also saw matching shares award under the company's 2011 deferred annual bonus awards as follows:

 

Nil Cost Option over Ordinary Shares

 

Conditional Awards of ADSs/Co-Investment Shares (ADSs)

Vested

Vested/Released

Sir Andrew Witty*

37,182

 

Dr Moncef Slaoui*

 

21,848

Mr S Bicknell

7,912

 

Ms D Connelly

 

5,280

Mr W Louv

 

2,392

Mr D Redfern

8,837

 

Ms C Thomas

1,967

 

Mr D Troy

 

10,950

Mr P Vallance

17,569

 

* Denotes an Executive Director

The following executives, who have since been appointed persons discharging managerial responsibilites, share options from the company's 2011 performance share plan awards vested as follows:

 

Awards vesting

Awards lapsed

Ordinary Shares

Ordinary Shares

Mr R Connor

4,260

2,224

Mr P Thomson

6,868

6,868

Ms E Walmsley

76,309

14,104

Mrs V Whyte

6,868

6,868

 

Awards vesting

Awards lapsed

ADSs

ADSs

Mr James Ford

3,923

3,923


Finally, K Thomson, a person connected to Senior Vice President of Global Communications Philip Thomson received 1,420 shares as options from the company's 2011 Performance Share Plan vested.

Shares in GlaxoSmithKline closed up 0.7% at 1,664.50 pence Friday afternoon.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @hanassallnews 


Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.